GlassScriptPhysician profile
Yasser Youssef
NPI 1700308376
$2,364.69
in general payments reported to CMS, 2019-2025
9 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.66 · 2021: $354 · 2022: $22.52 · 2023: $1,051 · 2024: $774 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,081 · Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,081.03 |
| Food and Beverage | $891.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,359.62 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $646.67 | 2021-2025 | Wavewriter Alpha Prime 16, Fixate, Na |
| Ipsen Biopharmaceuticals, INC | $150.00 | 2024 | Iqirvo |
| Abbvie INC. | $94.49 | 2024-2025 | |
| Avanos Medical | $33.32 | 2024 | Standard Rf Disposables |
| Vertex Pharmaceuticals Incorporated | $24.09 | 2025 | |
| Vertos Medical, INC. | $22.52 | 2022 | |
| Nevro Corp. | $18.32 | 2024 | Senza |
| Merck Sharp & Dohme LLC | $15.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasser Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.